The global anti-inflammatory biologics market share analysis is experiencing steady growth, projected to reach USD 183.7 billion by 2035, at a compound annual growth rate (CAGR) of 5.7% over the forecast years. Despite challenges such as the high cost of therapy and increasing competition from biosimilars, the market is expected to continue its trajectory of …